Reference : Epidemiology and reporting of candidaemia in Belgium
Scientific journals : Article
Life sciences : Microbiology
http://hdl.handle.net/2268/207665
Epidemiology and reporting of candidaemia in Belgium
English
[fr] Epidémiologie des candidémies en Belgique
Trouvé, Charlotte []
Blot, Stijn []
HAYETTE, Marie-Pierre mailto [Centre Hospitalier Universitaire de Liège - CHU > > Service de microbiologie clinique >]
Jonckheere, S. []
Patteet, Sophie []
Rodriguez-Villalobos, Hector []
Symoens, Françoise []
Van Wijngaerden, Eric []
Lagrou, Katrien mailto [KU LEUVEN > > > >]
17-Nov-2016
European Journal of Clinical Microbiology and Infectious Diseases
Springer
Yes (verified by ORBi)
International
0934-9723
1435-4373
Berlin
Germany
[en] candidemia ; epidemiology ; Belgium
[en] The primary aim of this study was to collect national epidemiological data on candidaemia and to determine the reporting time of species identification and antifungal susceptibility in clinical practice. During a 1-year period (March 2013 until February 2014), every first Candida isolate from each episode of candidaemia was included prospectively from 30 Belgian hospitals. Identification and susceptibility testing were performed according to local procedures and isolates were sent to the National Reference Center for Mycosis. Species identification was checked by matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry (MALDI-TOF MS) and internal transcribed spacer (ITS) sequencing in case no reliable identification was obtained by MALDI-TOF MS. Antifungal susceptibility testing was performed according to the European Committee on Antimicrobial Susceptibility Testing (EUCAST) methodology. A total of 355 isolates were retrieved from 338 patients. The mean incidence rate of candidaemia was 0.44 (range: 0.07 to 1.43) per 1000 admissions or 0.65 (range: 0.11 to 2.00) per 10,000 patient days. Candida albicans was most frequently found (50.4 %), followed by C. glabrata (27.3 %) and C. parapsilosis sensu lato (9.8 %). The overall resistance to fluconazole was 7.6 %, ranging from 3.9 % in C. albicans to 20.0 % in C. tropicalis. Only one C. glabrata isolate was resistant to the echinocandins. Four days after blood culture positivity, 99.7 % of the identifications and 90.3 % of the antifungal profiles were reported to the treating clinician. Candidaemia incidence rates differed up to 20-fold among Belgian hospitals; no clear factors explaining this difference were identified. The overall antifungal resistance rates were low but high azole resistance rates were recorded in C. tropicalis.
Researchers ; Professionals ; Students
http://hdl.handle.net/2268/207665
10.1007/s10096-016-2841-3

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Restricted access
TROUVE-pdf final.pdfPublisher postprint424.01 kBRequest copy

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.